FGEN
FibroGen, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website fibrogen.com
- Employees(FY) 592
- ISIN US31572Q8087
Performance
-1.64%
1W
-7.69%
1M
-45.21%
3M
+140.0%
6M
+35.39%
YTD
-93.27%
1Y
Profile
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Technical Analysis of FGEN 2024-05-10
Overview:
In analyzing the technical indicators for FGEN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-06 22:15
- 2024-05-06 20:57
Q1 2024 FibroGen Inc Earnings Call(Yahoo Finance)
- 2024-05-06 19:39
- 2024-05-06 19:36
Top Premarket Gainers(Yahoo Finance)
- 2024-05-06 19:00
FibroGen to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-05-06 15:14
- 2024-05-06 08:58
- 2024-05-06 04:25
FibroGen: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-06 04:02
FibroGen Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-28 19:00
FibroGen to Report First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-24 04:02
- 2024-04-02 21:32
- 2024-04-02 05:46
- 2024-03-25 19:00
- 2024-03-20 03:45
3 Nightmare Nasdaq Stocks Not Worth Holding Another Day(Yahoo Finance)
- 2024-03-10 19:00
FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer(Globenewswire)
- 2024-02-28 19:09
- 2024-02-26 20:59
Q4 2023 FibroGen Inc Earnings Call(Yahoo Finance)
- 2024-02-26 04:50
FibroGen: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-02-26 03:40
- 2024-02-26 03:34
- 2024-02-26 03:15
FibroGen regains rights to anemia drug from AstraZeneca(Yahoo Finance)
- 2024-02-26 03:06
- 2024-02-26 03:05
- 2024-02-19 18:00
- 2024-02-04 18:00
- 2024-01-24 18:00
- 2023-12-09 04:02
- 2023-11-06 22:01
- 2023-11-06 21:01
Q3 2023 FibroGen Inc Earnings Call(Yahoo Finance)
Page 1 of 5
previousnext